Lendlease Group (LLC)
Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026
Key indicators
| Last close | AUD 2.410 |
|---|---|
| 52-week range | 2.318 – 5.565 |
| Return, 1 month / 3 months | −3.6% / −14.0% |
| Return, 1 year / 3 years | −54.9% / −57.1% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 35.5% |
| Worst drawdown (1 year) | -56.6% |
| Average daily value traded | 7.88M AUD |
| Dividend yield | 6.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lendlease Group is an Australian property and infrastructure company based in Sydney. It develops and builds residential, commercial and urban regeneration projects, and it manages property and infrastructure assets and investment funds. Its customers include governments, institutional investors, businesses and home buyers, with activity across Australia, Asia, Europe and the Americas. The company works across development, construction and investment management, bringing these activities together on large urban projects and community developments.
The shares are listed on the Australian Securities Exchange in Australia under the code LLC, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lendlease Group (LLC) trades on the Australian Securities Exchange in Australia. It last closed at AUD 2.410 on 20 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 898 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 54.9% and over the last three months it fell 14.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 32 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -24.8% | ||
| From 52-week high | -56.0% | ||
| Momentum | 29 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.0% | ||
| 6-month return | -26.6% | ||
| 12-month return, skipping the last month | -53.2% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -56.6% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 7.88M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.5% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −0.4% |
|---|---|
| 1 month | −3.6% |
| 3 months | −14.0% |
| 6 months | −26.6% |
| 1 year | −54.9% |
| 3 years | −57.1% |
| 5 years | −73.8% |
Signals
| 50-day / 200-day average | 2.680 / 3.204 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.092 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Aug 2026 | AUD 0.0955 |
| 27 Feb 2026 | AUD 0.0621 |
| 22 Aug 2025 | AUD 0.1696 |
| 21 Feb 2025 | AUD 0.0604 |
| 23 Aug 2024 | AUD 0.0951 |
| 23 Feb 2024 | AUD 0.0649 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.